Provided by Tiger Trade Technology Pte. Ltd.

Insulet

148.16
+1.290.88%
Post-market: 148.160.00000.00%19:55 EDT
Volume:903.61K
Turnover:133.95M
Market Cap:10.26B
PE:27.97
High:150.20
Open:146.87
Low:145.04
Close:146.87
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:0.66
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:7.22
PE(LYR):42.59

Loading ...

UBS Downgrades Insulet to Neutral From Buy, Lowers Price Target to $174 From $400

MT Newswires Live
·
Jul 28

Is Insulet (PODD) A Bargain Following Its Calm Partnership?

Simply Wall St.
·
Jul 28

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 25

Dexcom Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 25

Insulet Corp. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Dexcom Inc. Stock Falls 4.4%, Underperforms Peers

Dow Jones
·
Jul 23

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 21

Dexcom Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Dexcom Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Insulet’s EVOLUTION T1D Trial Signals Next Step in Automated Insulin Delivery

TIPRANKS
·
Jul 18

Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects and Misleading Safety Claims

TIPRANKS
·
Jul 18

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 17

Dexcom Inc. Stock Climbs 7.2%, Outperforms Market

Dow Jones
·
Jul 17

Insulet Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Insulet, Calm Form Partnership Targeting Diabetes Community With Wellness Products

MT Newswires Live
·
Jul 14

Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 14

Insulet is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 13

Insulet price target lowered to $210 from $219 at Truist

TIPRANKS
·
Jul 13

Truist Lowers Price Target on Insulet to $210 From $219, Keeps Buy Rating

MT Newswires Live
·
Jul 13